NEWSROOM
News & Stories
Newsroom
Press Releases
ASCO 2021 Podium Presentation on Agendia FLEX Study Shows Clinical & Molecular Differences in Tumors of African American and Caucasian Patients with HR+ Breast Cancer, Underscores Importance of Genomic Insights to Understand Disparities in Outcomes
Transcriptomic differences found between Luminal tumors in African American and non-Hispanic White patients suggest race-associated biology and differences in outcome in breast tumors may result from the effects of structural violence and/or genetic ancestry Separate Read More
Inivata and Agendia Sign Agreement for Commercialization of RaDaRยฎ MRD Liquid Biopsy Assay in Breast Cancer
Inivataย and Agendiaย Sign Agreement for Commercialization of RaDaRยฎ MRDย Liquid Biopsyย Assayย in Breast Cancer Agendia grantedย co-exclusive distribution rights for RaDaRย inย North America and Europe Research Triangle Park, NC, USA, Cambridge, UK, Irvine, Calif., and Amsterdam โ 28 April 2021 Read More
Landmark Long-Term Data from EORTCโs MINDACT Study Published in The Lancet Oncology
IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ March 12, 2021 โ Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that long-term follow up data from MINDACT, the prospective, randomized trial Read More